Saturday, 10 October 20262:13 pm ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

India

TEVA Stock Hits Fresh 52-Week High As FDA Approves Monthly Schizophrenia Shot

Image: Asianet Newsable. Rights remain with the publisher.

The U.S. Food and Drug Administration approved Weltruza as an extended-release injectable suspension for adults with schizophrenia.

Read the full report on Asianet Newsable

Story file

Section
India
First reported by
Asianet Newsable
Reporter
stocktwits inc
Published
Saturday, 10 October 2026, 12:20 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Asianet Newsable with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More India news

See all